C. Graham

A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia

Jose M Garcia, W. Polvino, K. Kumor, 2007 .

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Jose M Garcia, R. Boccia, Ying Yan, 2015, The Lancet. Oncology.

Cetuximab plus FOLFOX for colorectal cancer (EXPLORE): Preliminary safety analysis of a randomized phase III trial.

C. Langer, E. Mitchell, S. Badarinath, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Open-Label, Multicenter, Three-Stage, Phase II Study of S-1 in Combination with Cisplatin as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer

R. Herbst, Dennie V. Jones, A. Sandler, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Jose M Garcia, R. Boccia, Ying Yan, 2015, The Lancet. Oncology.